RheOx Registry Study in Europe

NCT04182841 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Gala Therapeutics, Inc.